Panel votes to lower risk classification for certain balloon pumps

12/7/2012 | Clinica (subscription required)

An FDA panel has voted to recommend the reclassification of intra-aortic balloon pumps used in acute coronary syndrome, heart failure complications, and cardiac and non-cardiac procedures from Class III to Class II medical devices. The devices will now be subjected to the 510(k) clearance process instead of the tougher premarket approval program.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA